Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?

Objective: Attention-deficit hyperactivity disorder (ADHD) is common in adulthood, and it is associated with different high- risk behaviors, particularly substance use. Evidence suggests a high prevalence of ADHD in adults who take methamphetamine (METH). This study aimed at comparing functional lev...

Full description

Bibliographic Details
Main Authors: Zahra Shahrivar, Ronak Mihan, Javad Mahmoudi-Gharaei, Alia Shakiba, Mostafa Hosseini
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2018-04-01
Series:Iranian Journal of Psychiatry
Subjects:
Online Access:https://ijps.tums.ac.ir/index.php/ijps/article/view/1163
_version_ 1818326055350435840
author Zahra Shahrivar
Ronak Mihan
Javad Mahmoudi-Gharaei
Alia Shakiba
Mostafa Hosseini
author_facet Zahra Shahrivar
Ronak Mihan
Javad Mahmoudi-Gharaei
Alia Shakiba
Mostafa Hosseini
author_sort Zahra Shahrivar
collection DOAJ
description Objective: Attention-deficit hyperactivity disorder (ADHD) is common in adulthood, and it is associated with different high- risk behaviors, particularly substance use. Evidence suggests a high prevalence of ADHD in adults who take methamphetamine (METH). This study aimed at comparing functional level, quality of life, and psychiatric comorbidities in METH users with and without adult ADHD (A-ADHD). Method: In this cross-sectional study, 134 patients who had a history of METH use (at least once in lifetime) were selected from among inpatient and outpatient referrals to a psychiatric hospital. DIVA was performed for those who were positive on the Conners' Adult ADHD Rating Scales–Self-Report-Screening Version (CAARS-SR-SV). The Global Assessment of Functioning (GAF) and World Health Organization Quality of Life Scale-Brief (WHOQoL-BREF) were used to assess the participants’ level of functioning and quality of life, respectively. Psychiatric comorbidities including substance use disorders were evaluated using the Structured Clinical Interview for DSM-IV-Axis I (SCID-I). Results: Among the METH users, 10.4% were diagnosed as having A-ADHD. A-ADHD was more prevalent among female METH users than males. The hyperactive-impulsive and combined types were more common than the inattentive type. Opiates and cannabis were the most commonly abused drugs by the 2 groups, while sedative-hypnotic use was significantly higher in the individuals with A-ADHD. Substance-induced mood disorder was the most prevalent comorbidity in the 2 groups and was higher in those with A-ADHD. quality of life and the GAF scores were significantly lower in those with A-ADHD and duration of METH use was higher Compared to the METH users without A-ADHD, (p>0.05). Conclusion: This study provided some preliminary findings supporting the prevalence of Adult ADHD among METH users and its negative impacts on their global functioning and quality of life. To provide more effective intervention for METH users, detection and treatment of those with A-ADHD can be of clinical value.
first_indexed 2024-12-13T11:54:17Z
format Article
id doaj.art-fe6fb429ca294b149568d9aedbf5c987
institution Directory Open Access Journal
issn 1735-4587
2008-2215
language English
last_indexed 2024-12-13T11:54:17Z
publishDate 2018-04-01
publisher Tehran University of Medical Sciences
record_format Article
series Iranian Journal of Psychiatry
spelling doaj.art-fe6fb429ca294b149568d9aedbf5c9872022-12-21T23:47:16ZengTehran University of Medical SciencesIranian Journal of Psychiatry1735-45872008-22152018-04-01132623Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?Zahra Shahrivar0Ronak Mihan1Javad Mahmoudi-Gharaei2Alia Shakiba3Mostafa Hosseini4Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran. Research Center for Cognitive and Behavioral Sciences, Tehran University of Medical Sciences, Tehran, IranPsychiatry Faculty, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.Department of Psychiatry, Tehran University of Medical Sciences, Tehran, IranPsychiatry and Psychology Research Center, Tehran University of Medical Sciences, Tehran, IranDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.Objective: Attention-deficit hyperactivity disorder (ADHD) is common in adulthood, and it is associated with different high- risk behaviors, particularly substance use. Evidence suggests a high prevalence of ADHD in adults who take methamphetamine (METH). This study aimed at comparing functional level, quality of life, and psychiatric comorbidities in METH users with and without adult ADHD (A-ADHD). Method: In this cross-sectional study, 134 patients who had a history of METH use (at least once in lifetime) were selected from among inpatient and outpatient referrals to a psychiatric hospital. DIVA was performed for those who were positive on the Conners' Adult ADHD Rating Scales–Self-Report-Screening Version (CAARS-SR-SV). The Global Assessment of Functioning (GAF) and World Health Organization Quality of Life Scale-Brief (WHOQoL-BREF) were used to assess the participants’ level of functioning and quality of life, respectively. Psychiatric comorbidities including substance use disorders were evaluated using the Structured Clinical Interview for DSM-IV-Axis I (SCID-I). Results: Among the METH users, 10.4% were diagnosed as having A-ADHD. A-ADHD was more prevalent among female METH users than males. The hyperactive-impulsive and combined types were more common than the inattentive type. Opiates and cannabis were the most commonly abused drugs by the 2 groups, while sedative-hypnotic use was significantly higher in the individuals with A-ADHD. Substance-induced mood disorder was the most prevalent comorbidity in the 2 groups and was higher in those with A-ADHD. quality of life and the GAF scores were significantly lower in those with A-ADHD and duration of METH use was higher Compared to the METH users without A-ADHD, (p>0.05). Conclusion: This study provided some preliminary findings supporting the prevalence of Adult ADHD among METH users and its negative impacts on their global functioning and quality of life. To provide more effective intervention for METH users, detection and treatment of those with A-ADHD can be of clinical value.https://ijps.tums.ac.ir/index.php/ijps/article/view/1163AdultAttention Deficit Hyperactivity DisorderComorbidityFunctionMethamphetamineQuality of Life
spellingShingle Zahra Shahrivar
Ronak Mihan
Javad Mahmoudi-Gharaei
Alia Shakiba
Mostafa Hosseini
Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
Iranian Journal of Psychiatry
Adult
Attention Deficit Hyperactivity Disorder
Comorbidity
Function
Methamphetamine
Quality of Life
title Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
title_full Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
title_fullStr Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
title_full_unstemmed Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
title_short Attention-Deficit Hyperactivity Disorder in Adults Using Methamphetamine: Does It Affect Comorbidity, Quality of Life, and Global Functioning?
title_sort attention deficit hyperactivity disorder in adults using methamphetamine does it affect comorbidity quality of life and global functioning
topic Adult
Attention Deficit Hyperactivity Disorder
Comorbidity
Function
Methamphetamine
Quality of Life
url https://ijps.tums.ac.ir/index.php/ijps/article/view/1163
work_keys_str_mv AT zahrashahrivar attentiondeficithyperactivitydisorderinadultsusingmethamphetaminedoesitaffectcomorbidityqualityoflifeandglobalfunctioning
AT ronakmihan attentiondeficithyperactivitydisorderinadultsusingmethamphetaminedoesitaffectcomorbidityqualityoflifeandglobalfunctioning
AT javadmahmoudigharaei attentiondeficithyperactivitydisorderinadultsusingmethamphetaminedoesitaffectcomorbidityqualityoflifeandglobalfunctioning
AT aliashakiba attentiondeficithyperactivitydisorderinadultsusingmethamphetaminedoesitaffectcomorbidityqualityoflifeandglobalfunctioning
AT mostafahosseini attentiondeficithyperactivitydisorderinadultsusingmethamphetaminedoesitaffectcomorbidityqualityoflifeandglobalfunctioning